Fusion Pharmaceuticals Inc logo

Fusion Pharmaceuticals Inc

NAS:FUSN (Canada)   Ordinary Shares
$ 13.05 -0.04 (-0.31%) 10:08 PM EST
At Loss
P/B:
4.81
Market Cap:
$ 948.52M
Enterprise V:
$ 838.76M
Volume:
1.08M
Avg Vol (2M):
1.44M
Volume:
1.08M
At Loss
Avg Vol (2M):
1.44M

Business Description

Fusion Pharmaceuticals Inc logo
Fusion Pharmaceuticals Inc
NAICS : 541714 SIC : 3741
ISIN : CA36118A1003

Share Class Description:

FUSN: Ordinary Shares
Description
Fusion Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing alpha therapeutics for curing cancer. It develops Targeted Alpha Therapies (TAT) together with its proprietary Fast-Clear linker technology. The firm's lead product candidate comprises FPI-1434, a monotherapy for the treatment of a variety of cancers; FPI-1966, for the treatment of head and neck and bladder cancers; and FPI-2059 among others.
Name Current Vs Industry Vs History
Cash-To-Debt 3.64
Equity-to-Asset 0.74
Debt-to-Equity 0.28
Debt-to-EBITDA -0.61
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 6.6
Distress
Grey
Safe
Beneish M-Score -2.37
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -33.5
3-Year EPS without NRI Growth Rate -38.1
3-Year FCF Growth Rate -37.4
Name Current Vs Industry Vs History
5-Day RSI 71.7
9-Day RSI 69.62
14-Day RSI 68.46
6-1 Month Momentum % 233.22
12-1 Month Momentum % 94.99

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 11.63
Quick Ratio 11.63
Cash Ratio 10.95
Days Sales Outstanding 15.47

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -2.5
Shareholder Yield % -12.53

Profitability Rank

Name Current Vs Industry Vs History
Operating Margin % -4319.48
Net Margin % -4136.55
FCF Margin % -3921.11
ROE % -48.71
ROA % -36.66
ROIC % -181.36
ROC (Joel Greenblatt) % -476.73
ROCE % -37.41

Financials (Next Earnings Date:2024-03-15 Est.)

FUSN's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:FUSN

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Fusion Pharmaceuticals Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 2.208
EPS (TTM) ($) -1.63
Beta -0.92
Volatility % 121.66
14-Day RSI 68.46
14-Day ATR ($) 0.911021
20-Day SMA ($) 11.5625
12-1 Month Momentum % 94.99
52-Week Range ($) 2.31 - 13.99
Shares Outstanding (Mil) 72.41

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Fusion Pharmaceuticals Inc Filings

Filing Date Document Date Form
No Filing Data

Fusion Pharmaceuticals Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Fusion Pharmaceuticals Inc Frequently Asked Questions

What is Fusion Pharmaceuticals Inc(FUSN)'s stock price today?
The current price of FUSN is $13.05. The 52 week high of FUSN is $13.99 and 52 week low is $2.31.
When is next earnings date of Fusion Pharmaceuticals Inc(FUSN)?
The next earnings date of Fusion Pharmaceuticals Inc(FUSN) is 2024-03-15 Est..
Does Fusion Pharmaceuticals Inc(FUSN) pay dividends? If so, how much?
Fusion Pharmaceuticals Inc(FUSN) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1